Paper798024
Further investigations on the mode of entry of vaccinia virus into cells.
Chang A and 1 other. J Gen Virol, 1976. Cited by 113 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Further investigations on the mode of entry of vaccinia virus into cells. Papers, record 798024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/798024
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vaccinia virus | Major topic |
| Adsorption | |
| Antigens, Viral | |
| Cell Membrane | |
| Ferritins | |
| HeLa Cells | |
| Immunologic Techniques | |
| L Cells |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,405,773 | Structure and functional analyses of vaccinia virus J5 protein reveal distinct determinants for entry-fusion complex assembly and activation. | J Virol | 2026 | https://conductscience.org/library/papers/42405773 | PubMed |
| 38,148,355 | Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/38148355 | PubMed |
| 37,948,471 | Structural and functional analysis of vaccinia viral fusion complex component protein A28 through NMR and molecular dynamic simulations. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37948471 | PubMed |
| 35,967,174 | Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment. | Cureus | 2022 | https://conductscience.org/library/papers/35967174 | PubMed |
| 31,220,181 | Vaccinia viral A26 protein is a fusion suppressor of mature virus and triggers membrane fusion through conformational change at low pH. | PLoS Pathog | 2019 | https://conductscience.org/library/papers/31220181 | PubMed |
| 28,659,486 | Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein. | J Virol | 2017 | https://conductscience.org/library/papers/28659486 | PubMed |
| 26,041,286 | Intracellular Transport of Vaccinia Virus in HeLa Cells Requires WASH-VPEF/FAM21-Retromer Complexes and Recycling Molecules Rab11 and Rab22. | J Virol | 2015 | https://conductscience.org/library/papers/26041286 | PubMed |
| 22,359,015 | Effect of serum type and concentration on the expression ofβ-galactosidase in recombinant vaccinia virus infected HeLa S3 cells. | Cytotechnology | 1995 | https://conductscience.org/library/papers/22359015 | PubMed |
| 22,345,471 | The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis. | J Virol | 2012 | https://conductscience.org/library/papers/22345471 | PubMed |
| 22,278,246 | Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH. | J Virol | 2012 | https://conductscience.org/library/papers/22278246 | PubMed |
| 21,994,664 | Lipid membranes in poxvirus replication. | Viruses | 2010 | https://conductscience.org/library/papers/21994664 | PubMed |
| 20,538,855 | Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells. | J Virol | 2010 | https://conductscience.org/library/papers/20538855 | PubMed |
| 20,526,370 | Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis. | PLoS One | 2010 | https://conductscience.org/library/papers/20526370 | PubMed |
| 19,428,041 | Vaccinia virus strain differences in cell attachment and entry. | Virology | 2009 | https://conductscience.org/library/papers/19428041 | PubMed |
| 19,395,056 | Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide. | Virology | 2009 | https://conductscience.org/library/papers/19395056 | PubMed |
| 19,369,327 | Disulfide bond formation at the C termini of vaccinia virus A26 and A27 proteins does not require viral redox enzymes and suppresses glycosaminoglycan-mediated cell fusion. | J Virol | 2009 | https://conductscience.org/library/papers/19369327 | PubMed |
| 19,264,647 | Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. | J Gen Virol | 2009 | https://conductscience.org/library/papers/19264647 | PubMed |
| 19,162,290 | Vaccinia virus exhibits cell-type-dependent entry characteristics. | Virology | 2009 | https://conductscience.org/library/papers/19162290 | PubMed |
| 19,036,815 | Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. | J Virol | 2009 | https://conductscience.org/library/papers/19036815 | PubMed |
| 18,550,675 | A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. | J Virol | 2008 | https://conductscience.org/library/papers/18550675 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/798024
GET https://conductscience.org/api/papers/v1/798024/cited_by?page=2